X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-28 | BDTX | Versant Venture Capital Vi, L.P. | 10% | S - Sale | $6.32 | -221,600 | 6,206,964 | -3% | -$1,400,556 | ||||||
2023-10-17 | BDTX | Biotech Growth N V | 10% | P - Purchase | $2.34 | +400,000 | 8,517,839 | +5% | +$934,080 | ||||||
2023-07-05 | BDTX | Ra Capital Management, L.P. | Dir | P - Purchase | $5.00 | +935,850 | 3,525,754 | +36% | +$4,679,250 | ||||||
2023-07-05 | BDTX | Behbahani Ali | Dir | P - Purchase | $5.00 | +1,000,000 | 4,489,527 | +29% | +$5,000,000 | ||||||
2023-06-30 | BDTX | Biotech Growth N V | 10% | P - Purchase | $5.00 | +1,000,000 | 8,117,839 | +14% | +$5,000,000 | ||||||
2023-06-27 | BDTX | Biotech Growth N V | 10% | P - Purchase | $5.49 | +1,740,000 | 7,117,839 | +32% | +$9,555,036 | ||||||
2023-06-27 | BDTX | Epstein David M. | SEE REMARKS | S - Sale | $6.70 | -25,000 | 936,569 | -3% | -$167,500 | ||||||
| M | 2022-12-21 | BDTX | Ni Fang | SEE REMARKS | P - Purchase | $1.28 | +56,363 | 125,389 | +82% | +$72,366 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |